Price Chart
Insider Transactions
| Date | Insider | Dir. | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Khouri, Amal | Buy | 774 | $7K |
| Jun 15, 2026 | Khouri, Amal | Buy | 593 | $3K |
| Jun 15, 2026 | Utchanah, Arvind | Buy | 695 | $7K |
| Jun 15, 2026 | Utchanah, Arvind | Buy | 296 | $2K |
| Jun 15, 2026 | Goodman, Jonathan Ross | Buy | 718 | $7K |
| Jun 15, 2026 | Goodman, Jonathan Ross | Buy | 267 | $1K |
| Jun 15, 2026 | Emblem, Susan Caroline | Buy | 876 | $8K |
| Jun 15, 2026 | Emblem, Susan Caroline | Buy | 361 | $2K |
| Jun 15, 2026 | Sakhia, Samira | Buy | 1,934 | $18K |
| Jun 15, 2026 | Sakhia, Samira | Buy | 720 | $4K |
| Jun 15, 2026 | Dos Santos Dias, Henrique José | Buy | 140 | $731 |
| Jun 15, 2026 | Lopez, German | Buy | 794 | $7K |
| Jun 15, 2026 | Lopez, German | Buy | 200 | $1K |
| Jun 10, 2026 | Groleau, Melanie | Sell | 4,390 | $27K |
| Jun 10, 2026 | Groleau, Melanie | Buy | 4,390 | $27K |
| Jun 10, 2026 | Groleau, Melanie | Buy | 4,390 | $41K |
| Jun 10, 2026 | Groleau, Melanie | Sell | 4,039 | $23K |
| Jun 10, 2026 | Groleau, Melanie | Buy | 4,039 | $23K |
| Jun 10, 2026 | Groleau, Melanie | Buy | 4,039 | $37K |
| Jun 10, 2026 | Groleau, Melanie | Sell | 4,039 | $23K |
| Jun 10, 2026 | Groleau, Melanie | Sell | 1,709 | $12K |
| Jun 10, 2026 | Groleau, Melanie | Buy | 1,709 | $12K |
| Jun 10, 2026 | Groleau, Melanie | Buy | 1,709 | $16K |
| Jun 10, 2026 | Groleau, Melanie | Sell | 5,129 | $36K |
| Jun 10, 2026 | Groleau, Melanie | Buy | 5,129 | $36K |
| Jun 10, 2026 | Groleau, Melanie | Buy | 5,129 | $47K |
| Jun 10, 2026 | Groleau, Melanie | Sell | 29,403 | $227K |
| Jun 10, 2026 | Groleau, Melanie | Buy | 29,403 | $227K |
| Jun 10, 2026 | Groleau, Melanie | Buy | 29,403 | $272K |
Score uses open-market buys only
· 5 open-market
· 18 plan / compensation shown but not scored
· Return is unrealized, to today's price; a
“· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
| Component | Points | Max |
|---|---|---|
| Conviction (unique buyers) ✓ FREE PREVIEW | 30 | 30 |
| Buy/sell ratio | 20 | |
| Dollar value | 25 | |
| Lobbying activity | 15 | |
| Contract wins | 10 | |
| Insider track record | 10 | |
| Private placements | 8 | |
| Confluence bonus | 10 | |
| Cluster timing (velocity) | 10 | |
| Buy/sell reversal pattern | 8 | |
| Total | 0 | 100 |
Buying Insiders
| Insider | Credibility | Buy Value (90d) |
|---|---|---|
| Groleau, Melanie | — | $413K |
Credibility score: historical hit rate × avg 90d return × sample size.
View full insider leaderboard →
Lobbying Registrations
No active OCL lobbying registrations in the last 90 days.
Analyst plan →
Government Contract Wins
No government contract wins in the last 90 days.
Analyst plan →
Private Placements
Private placement history, deal size, and lock-up expiry tracking.
Analyst plan →
Indigenous Consultation
No Indigenous consultation records on file for GUD.
SEDAR+ Filings
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes.
Search SEDAR+ →
Short Interest
Shares short
1,415,789
Net change
-204,098
(-12.6%)
History
Jun 30:
1,415,789
Jun 15:
1,619,887
May 31:
1,729,108
May 15:
1,801,807
Apr 30:
1,861,011
Apr 15:
1,912,154
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Wikipedia Attention
Views (30d)
653
Daily English-Wikipedia pageviews (Wikimedia). Traffic spikes often coincide with news — a
public-attention indicator, not investment advice.
Clinical Trials
Trials where this company is the lead sponsor (ClinicalTrials.gov). Phase advances, completions and
terminations are material catalysts for clinical-stage companies — not investment advice.